Selina Luger 🇺🇸
8:00 AM - 8:20 AM
Day 3 | Hematology Track
The Role of Targeted Agents in AML Therapy
8:40 AM - 9:00 AM
Day 3 | Hematology Track
MyeloMATCH / Clinical Paradigms in Clinical Trials
8:20 AM - 8:40 AM
Day 2 | Hematology Track
Evolving concepts in MRD and adult B-ALL
8:20 AM - 8:40 AM
Day 3 | | Hematology Track
An update on immune checkpoint inhibition in management of higher risk MDS
8:20 AM - 8:40 AM
Day 2 | | Hematology Track
Evolving concepts in MRD and adult B-ALL